Michael Foster Buys 8,310 Shares of Sabra Health Care REIT, Inc.
Michael Foster acquired 8,310 shares of Sabra Health Care REIT, Inc. on June 17, 2026.
Key Points
- Michael Foster purchased 8,310 shares of Sabra Health Care REIT, Inc. on June 17, 2026, with the stock trading at $18.05.
- Sabra Health Care REIT, Inc. has a market cap of $4.57 billion and a P/E ratio of 28.76, with a 52-week range between $17.17 and $21.28.
- Analysts from Wells Fargo and Scotiabank have maintained their ratings, with price targets of $23.00 and $19.00, respectively.
Michael Foster made a notable purchase of 8,310 shares of Sabra Health Care REIT, Inc. (NasdaqGS: SBRA) on June 17, 2026. Despite the transaction being recorded at a price of $0.00, the stock was trading at $18.05 at the time. This move reflects a strategic acquisition in the healthcare real estate sector.
Other Institutional Activity in Sabra Health Care REIT, Inc.
Several major institutional investors have been active in Sabra Health Care REIT, Inc. BlackRock, Inc. increased its holdings by 704,770 shares, bringing its total to 39,098,389 shares valued at approximately $751.86 million. Principal Financial Group Inc. also added 98,770 shares, resulting in 25,052,121 shares worth about $481.75 million. Meanwhile, JPMorgan Chase & Co. significantly boosted its position by 5,569,621 shares, ending with 8,201,220 shares valued at $159.43 million.
Sabra Health Care REIT, Inc. Stock Snapshot
Shares of Sabra Health Care REIT, Inc. (NasdaqGS: SBRA) traded near $18.05. The company boasts a market capitalization of approximately $4.57 billion and a P/E ratio of 28.76. The stock's 52-week range spans from $17.17 to $21.28. Sabra Health Care REIT maintains a 50-day moving average of $19.94 and a 200-day moving average of $19.31. The company has a current ratio of 2.62 and a debt-to-equity ratio of 95.86.
Recent Earnings
For its most recent quarter, Sabra Health Care REIT, Inc. reported revenue of $815.66 million, with a growth rate of 21.7%. The company achieved a net margin of 19.15% and a return on equity of 5.68%. Earnings per share stood at $0.63. The next earnings announcement is scheduled for August 3, 2026.
Insider Buying and Selling at Sabra Health Care REIT, Inc.
On June 17, 2026, several insiders, including Michael Foster, purchased 8,310 shares each of Sabra Health Care REIT, Inc. Other insiders involved in similar transactions on the same day include Ann Kono, Lynne Katzmann, Catherine Cusack, Jeffrey Malehorn, and Craig Barbarosh. These purchases were not part of any pre-planned trading programs.
Analysts Set New Price Targets
On June 18, 2026, Scotiabank maintained its "hold" rating for Sabra Health Care REIT, Inc., setting a price target of $19.00. Earlier, on June 1, 2026, Wells Fargo reiterated its "buy" rating with a target of $23.00. Overall, the consensus among 13 analysts is a "buy" rating, with an average target price of $22.77.
About Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. is a real estate investment trust that focuses on owning and investing in properties within the healthcare sector across the United States and Canada. Headquartered in Tustin, California, and led by CEO Richard K. Matros, the company was established in 2010 and employs about 58 people.
Bottom Line
Michael Foster's recent acquisition of Sabra Health Care REIT, Inc. shares highlights ongoing interest in the healthcare real estate sector. Investors and analysts closely watch these moves, as they can provide insights into market sentiment. Remember, insider transactions are disclosed after the fact and may not indicate current positions.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.